ERBB3 and head and neck squamous cell carcinoma: Studies have demonstrated overexpression of alternative members of the RTK family, notably ErbB2/HER2 and ErbB3/HER3, in SCCHN which confer treatment resistance by promoting growth and poor differentiation [22].